Biologics eat 51% of drug spending despite 5% of prescriptions, but FDA's new draft guidance hopes more competition can close that gap.
In this world, there are three types of design: good, not so good, and absolutely evil. That last category is very real. It goes way beyond mild irritation—it’s the kind of design that makes you want ...